Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BonoFill-II in maxillofacial bone reconstruction
NCT02842619Phase 2Completed
- Sponsor
- Bonus BioGroup
- Start
- Jul 2016
- Primary completion
- Jun 2024
- Modality
- Implantable Devices, Implantable Hydrogels, Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of BonoFill-II, sponsored by Bonus BioGroup. Primary endpoints: Safety of BonoFill-II Administration at 6 months and Efficacy of BonoFill-II Administration at 6 months. Started Jul 2016; status: completed.
02
Drugs
BonoFill-II
Beyond the preview
Go deeper on NCT02842619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02842619.